{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T18:15:17Z","timestamp":1790360117970,"version":"4.1.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Chromatography A"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/j.chroma.2018.10.006","type":"journal-article","created":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T03:48:08Z","timestamp":1539056888000},"page":"83-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"special_numbering":"C","title":["A capillary zone electrophoresis method to investigate the oligomerization of the human Islet Amyloid Polypeptide involved in Type 2 Diabetes"],"prefix":"10.1016","volume":"1578","author":[{"given":"Corentin","family":"Berardet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kaffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Ongeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Taverna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.chroma.2018.10.006_bib0005","doi-asserted-by":"crossref","first-page":"6","DOI":"10.3389\/fendo.2017.00006","article-title":"Clinical review of antidiabetic drugs: implications for type 2 diabetes mellitus management","volume":"8","author":"Chaudhury","year":"2017","journal-title":"Front. Endocrinol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0010","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res. Clin. Pract."},{"key":"10.1016\/j.chroma.2018.10.006_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat. Rev. Endocrinol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0020","doi-asserted-by":"crossref","first-page":"2798269","DOI":"10.1155\/2016\/2798269","article-title":"Polypeptide: structure, function, and pathophysiology","volume":"2016","author":"Akter","year":"2016","journal-title":"J. Diabetes Res"},{"key":"10.1016\/j.chroma.2018.10.006_bib0025","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1152\/physrev.00042.2009","article-title":"Islet amyloid polypeptide, Islet amyloid, and diabetes mellitus","volume":"91","author":"Westermark","year":"2011","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.chroma.2018.10.006_bib0030","doi-asserted-by":"crossref","first-page":"826706","DOI":"10.1155\/2013\/826706","article-title":"Amylin uncovered: a review on the polypeptide responsible for type II diabetes","volume":"2013","author":"Pillay","year":"2013","journal-title":"Biomed. Res. Int."},{"key":"10.1016\/j.chroma.2018.10.006_bib0035","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/j.febslet.2013.01.017","article-title":"Mechanisms of islet amyloidosis toxicity in type 2 diabetes","volume":"587","author":"Abedini","year":"2013","journal-title":"FEBS Lett."},{"key":"10.1016\/j.chroma.2018.10.006_bib0040","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.molmed.2015.04.005","article-title":"Type 2 diabetes as a protein misfolding disease","volume":"21","author":"Mukherjee","year":"2015","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.chroma.2018.10.006_bib0045","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.bpc.2010.12.007","article-title":"Comparing the structural properties of human and rat islet amyloid polypeptide by MD computer simulations","volume":"156","author":"Andrews","year":"2011","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0050","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1210\/er.2007-0037","article-title":"Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis","volume":"29","author":"Haataja","year":"2008","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.chroma.2018.10.006_bib0055","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.bpj.2012.01.039","article-title":"How type II diabetes-related islet amyloid polypeptide damages lipid bilayers","volume":"102","author":"Lee","year":"2012","journal-title":"Biophys. J."},{"key":"10.1016\/j.chroma.2018.10.006_bib0060","doi-asserted-by":"crossref","first-page":"S253","DOI":"10.2337\/dc09-S318","article-title":"Insulin therapy for type 2 diabetes","volume":"32","author":"Swinnen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.chroma.2018.10.006_bib0065","doi-asserted-by":"crossref","first-page":"413","DOI":"10.4103\/2230-8210.111625","article-title":"Glucagon-like peptide-1 analogues: an overview","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J. Endocrinol. Metab."},{"key":"10.1016\/j.chroma.2018.10.006_bib0070","doi-asserted-by":"crossref","first-page":"e143","DOI":"10.1038\/nutd.2014.40","article-title":"Efficacy, safety and regulatory status of SGLT2 inhibitors: focus on canagliflozin","volume":"4","author":"Haas","year":"2014","journal-title":"Nutr. Diabetes"},{"key":"10.1016\/j.chroma.2018.10.006_bib0075","doi-asserted-by":"crossref","first-page":"8478","DOI":"10.1021\/bi300574r","article-title":"Ionic strength effects on amyloid formation by amylin are a complicated interplay among Debye screening, ion selectivity, and Hofmeister effects","volume":"51","author":"Marek","year":"2012","journal-title":"Biochemistry"},{"key":"10.1016\/j.chroma.2018.10.006_bib0080","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ab.2017.06.007","article-title":"Thioflavin T fluorescence to analyse amyloid formation kinetics: measurement frequency as a factor explaining irreproducibility","volume":"532","author":"Sebastiao","year":"2017","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0085","doi-asserted-by":"crossref","first-page":"5235","DOI":"10.1074\/jbc.M111.327817","article-title":"Fibril structure of human islet amyloid polypeptide","volume":"287","author":"Bedrood","year":"2012","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0090","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/j.jmb.2003.11.048","article-title":"Structural characterisation of islet amyloid polypeptide fibrils","volume":"335","author":"Sumner Makin","year":"2004","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0095","doi-asserted-by":"crossref","DOI":"10.1038\/srep04267","article-title":"Apoptosis induced by islet amyloid polypeptide soluble oligomers is neutralized by diabetes-associated specific antibodies","volume":"4","author":"Bram","year":"2014","journal-title":"Sci. Rep."},{"key":"10.1016\/j.chroma.2018.10.006_bib0100","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1021\/ja406831n","article-title":"Ion mobility spectrometry-mass spectrometry defines the oligomeric intermediates in amylin amyloid formation and the mode of action of inhibitors","volume":"136","author":"Young","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chroma.2018.10.006_bib0105","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nchem.2129","article-title":"Screening and classifying small-molecule inhibitors of amyloid formation using ion mobility spectrometry-mass spectrometry","volume":"7","author":"Young","year":"2015","journal-title":"Nat. Chem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0110","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymeth.2015.05.017","article-title":"ESI-IMS-MS: a method for rapid analysis of protein aggregation and its inhibition by small molecules","volume":"95","author":"Young","year":"2016","journal-title":"Methods"},{"key":"10.1016\/j.chroma.2018.10.006_bib0115","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1098\/rsif.2011.0823","article-title":"Two decades of studying non-covalent biomolecular assemblies by means of electrospray ionization mass spectrometry","volume":"9","author":"Hilton","year":"2012","journal-title":"J. R. Soc. Interface"},{"key":"10.1016\/j.chroma.2018.10.006_bib0120","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.bpc.2013.07.013","article-title":"Stepwise oligomerization of murine amylin and assembly of amyloid fibrils","volume":"180\u2013181","author":"Palmieri","year":"2013","journal-title":"Biophys. Chem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0125","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1110\/ps.9.2.427","article-title":"Direct measurement of islet amyloid polypeptide fibrillogenesis by mass spectrometry","volume":"9","author":"Larson","year":"2000","journal-title":"Protein Sci."},{"key":"10.1016\/j.chroma.2018.10.006_bib0130","doi-asserted-by":"crossref","first-page":"12912","DOI":"10.1021\/ja504031d","article-title":"Defining the molecular basis of amyloid inhibitors: human islet amyloid polypeptide-insulin interactions","volume":"136","author":"Susa","year":"2014","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chroma.2018.10.006_bib0135","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijms.2015.09.001","article-title":"On the structure of the copper-amylin complex","volume":"391","author":"Riba","year":"2015","journal-title":"Int. J. Mass Spectrom."},{"key":"10.1016\/j.chroma.2018.10.006_bib0140","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.jsb.2005.06.006","article-title":"Mechanism of thioflavin T binding to amyloid fibrils","volume":"151","author":"Khurana","year":"2005","journal-title":"J. Struct. Biol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0145","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.bbapap.2010.04.001","article-title":"Molecular mechanism of Thioflavin-T binding to amyloid fibrils","volume":"1804","author":"Biancalana","year":"2010","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.chroma.2018.10.006_bib0150","doi-asserted-by":"crossref","first-page":"3670","DOI":"10.1016\/j.tetlet.2015.02.132","article-title":"Amphiphilic oligoamide \u03b1-helix peptidomimetics inhibit islet amyloid polypeptide aggregation","volume":"56","author":"Kulikov","year":"2015","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.chroma.2018.10.006_bib0155","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1016\/j.chembiol.2014.05.007","article-title":"Folded small molecule manipulation of islet amyloid polypeptide","volume":"21","author":"Kumar","year":"2014","journal-title":"Chem. Biol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0160","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1039\/c3cc41452c","article-title":"A foldamer approach to targeting membrane bound helical states of islet amyloid polypeptide","volume":"49","author":"Kumar","year":"2013","journal-title":"Chem. Commun."},{"key":"10.1016\/j.chroma.2018.10.006_bib0165","doi-asserted-by":"crossref","first-page":"15240","DOI":"10.1039\/C5RA27689F","article-title":"Influence of trehalose on human islet amyloid polypeptide fibrillation and aggregation","volume":"6","author":"Chen","year":"2016","journal-title":"RSC Adv."},{"key":"10.1016\/j.chroma.2018.10.006_bib0170","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1002\/elps.201400271","article-title":"An improved capillary electrophoresis method for in vitro monitoring of the challenging early steps of Abeta1-42 peptide oligomerization: application to anti-Alzheimer\u2019s drug discovery","volume":"35","author":"Brinet","year":"2014","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2018.10.006_bib0175","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1002\/elps.200406062","article-title":"Capillary electrophoresis studies on the aggregation process of \u03b2-amyloid 1-42 and 1-40 peptides","volume":"25","author":"Sabella","year":"2004","journal-title":"Electrophoresis"},{"key":"10.1016\/j.chroma.2018.10.006_bib0180","doi-asserted-by":"crossref","first-page":"033105","DOI":"10.1063\/1.4954051","article-title":"Field amplified sample stacking of amyloid beta (1-42) oligomers using capillary electrophoresis","volume":"10","author":"Paracha","year":"2016","journal-title":"Biomicrofluidics"},{"key":"10.1016\/j.chroma.2018.10.006_bib0185","doi-asserted-by":"crossref","first-page":"2046327","DOI":"10.1155\/2016\/2046327","article-title":"Inhibition of IAPP aggregation and toxicity by natural products and derivatives","volume":"2016","author":"Pithadia","year":"2016","journal-title":"J. Diabetes Res."},{"key":"10.1016\/j.chroma.2018.10.006_bib0190","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2174\/138161212798919075","article-title":"Resveratrol, a neuroprotective supplement for Alzheimer\u2019s disease","volume":"18","author":"Li","year":"2012","journal-title":"Curr. Pharm. Des."},{"key":"10.1016\/j.chroma.2018.10.006_bib0195","doi-asserted-by":"crossref","first-page":"2408","DOI":"10.1002\/jssc.200900164","article-title":"Capillary electrophoresis of intact basic proteins using noncovalently triple-layer coated capillaries","volume":"32","author":"Haselberg","year":"2009","journal-title":"J. Sep. Sci."},{"key":"10.1016\/j.chroma.2018.10.006_bib0200","doi-asserted-by":"crossref","first-page":"15598","DOI":"10.1021\/ja205007j","article-title":"Low pH acts as inhibitor of membrane damage induced by human Islet amyloid polypeptide","volume":"133","author":"Khemt\u00e9mourian","year":"2011","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.chroma.2018.10.006_bib0205","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1021\/bi401164k","article-title":"pH Dependence of Amylin Fibrillization","volume":"53","author":"Jha","year":"2014","journal-title":"Biochemistry"},{"key":"10.1016\/j.chroma.2018.10.006_bib0210","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0378-4347(97)00022-4","article-title":"Capillary electrophoresis of peptides and proteins at neutral pH in capillaries covalently coated with polyethyleneimine","volume":"695","author":"Figeys","year":"1997","journal-title":"J. Chromatogr. B"},{"key":"10.1016\/j.chroma.2018.10.006_bib0215","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/0021-9673(95)00394-3","article-title":"Performance of a physically adsorbed High-molecular-mass polyethyleneimine layer as coating for the separation of basic-proteins and peptides by capillary electrophoresis","volume":"708","author":"Erim","year":"1995","journal-title":"J. Chromatogr. A"},{"key":"10.1016\/j.chroma.2018.10.006_bib0220","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0076-6879(09)63020-2","article-title":"Chapter 20 protein precipitation techniques","volume":"463","author":"Burgess","year":"2009","journal-title":"Methods Enzymol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0225","doi-asserted-by":"crossref","first-page":"R121","DOI":"10.1530\/JME-17-0105","article-title":"The beta-cell assassin: IAPP cytotoxicity","volume":"59","author":"Raleigh","year":"2017","journal-title":"J. Mol. Endocrinol."},{"key":"10.1016\/j.chroma.2018.10.006_bib0230","doi-asserted-by":"crossref","first-page":"6291","DOI":"10.1074\/jbc.M110.166678","article-title":"The molecular basis of distinct aggregation pathways of islet amyloid polypeptide","volume":"286","author":"Wei","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.chroma.2018.10.006_bib0235","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1021\/bi501016r","article-title":"Mutational analysis of the ability of resveratrol to inhibit amyloid formation by Islet amyloid polypeptide: critical evaluation of the importance of Aromatic\u2013inhibitor and Histidine\u2013inhibitor interactions","volume":"54","author":"Tu","year":"2015","journal-title":"Biochemistry"}],"container-title":["Journal of Chromatography A"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967318312500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021967318312500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,9,3]],"date-time":"2022-09-03T16:37:18Z","timestamp":1662223038000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021967318312500"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,11]]},"references-count":47,"alternative-id":["S0021967318312500"],"URL":"https:\/\/doi.org\/10.1016\/j.chroma.2018.10.006","relation":{},"ISSN":["0021-9673"],"issn-type":[{"value":"0021-9673","type":"print"}],"subject":[],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A capillary zone electrophoresis method to investigate the oligomerization of the human Islet Amyloid Polypeptide involved in Type 2 Diabetes","name":"articletitle","label":"Article Title"},{"value":"Journal of Chromatography A","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.chroma.2018.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}